1.Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence is not a edictive factor for response to interferon-alpha therapy and development of patocellular carcinoma.
Si Hyun BAE ; Young Min PARK ; Duck Gi YOO ; Jong Young CHOI ; Byung Hun BYUN ; Jin Mo YANG ; Chang Don LEE ; Sang Bok CHA ; Doo Ho PARK ; Boo Sung KIM
Journal of Korean Medical Science 2000;15(1):53-58
Genetic changes between codons 2209 and 2248 of NS5A of genotype 1b hepatitis C virus (HCV-1b) have been reported to be associated with the sensitivity to interferon-alpha (IFN-alpha). The present study was performed to analyze such relationship in Korean patients with chronic hepatitis C and HCV-1b (n=19), including 12 chronic hepatitis C patients treated with IFN-alpha, 3 chronic hepatitis C patients without treatment as controls, and 4 patients with hepatocellular carcinoma (HCC). Two serum samples, before and after the treatment, were analyzed for the mutations by reverse transcription-polymerase chain reaction, cloning and sequencing. The mutations were identified in 32% (6/19), including five intermediate type (1-3 mutations) and one mutant type (4 or more). In 12 patients treated with IFN-alpha, the number of amino acid substitutions in NS5A2209-2248 was not associated with outcome of the treatment.
Adult
;
Aged
;
Amino Acid Sequence
;
Antiviral Agents/therapeutic use*
;
Base Sequence
;
Carcinoma, Hepatocellular/virology*
;
Carcinoma, Hepatocellular/blood
;
Codon
;
Female
;
Genotype
;
Hepatitis C, Chronic/virology*
;
Hepatitis C, Chronic/drug therapy*
;
Hepatitis C, Chronic/blood
;
Hepatitis C-Like Viruses/isolation & purification
;
Hepatitis C-Like Viruses/genetics*
;
Hepatitis C-Like Viruses/classification
;
Human
;
Interferon-alpha/therapeutic use*
;
Liver Neoplasms/virology*
;
Liver Neoplasms/blood
;
Male
;
Middle Age
;
Molecular Sequence Data
;
Mutation*
;
Prognosis
;
Reverse Transcriptase Polymerase Chain Reaction